Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.

ABSTRACT:

SUBMITTER: Evens AM 

PROVIDER: S-EPMC9314600 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature